Ting An

Title: Innovations and Contributions of Inventor Ting An

Introduction

Ting An is a prominent inventor based in Guangdong, China, known for his significant contributions to the field of cancer research. With a total of six patents to his name, he has made remarkable strides in developing novel therapeutic approaches for cancer treatment.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Tumor-specific polypeptide and use thereof." This invention focuses on a novel tumor-specific polypeptide that exhibits a high affinity for HLA-A0201 and possesses the ability to induce cytotoxic T lymphocytes. It is particularly relevant for diagnosing, preventing, and treating diseases associated with high expression or mutations in the TWISTNB gene. Another notable patent is the "Col14A1-derived tumor antigen polypeptide and use thereof." This patent provides a tumor antigen polypeptide with a specific amino acid sequence, along with various related constructs and cells, aimed at enhancing the diagnosis, prevention, and treatment of cancers.

Career Highlights

Ting An is currently affiliated with Genoimmune Therapeutics Co., Ltd., where he continues to innovate and contribute to the advancement of cancer therapies. His work is characterized by a strong focus on the development of immunotherapeutic strategies that leverage the body's immune system to combat cancer.

Collaborations

Ting An collaborates with esteemed colleagues, including Yong Hou and Shuntao Luo, who contribute to his research endeavors and enhance the impact of his innovations in the field.

Conclusion

Ting An's work exemplifies the vital role of innovation in the fight against cancer. His patents and ongoing research efforts are paving the way for new therapeutic options that could significantly improve patient outcomes.